Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Cephalosporin tested in Italian patients with ALS

Oct. 25, 1996

Talipexole now available in Japan

Oct. 25, 1996

Neuroprotective calpain inhibitors from Warner-Lambert

Oct. 18, 1996

Huperzine A analogues claimed for treatment of AD

Oct. 18, 1996

Lilly's benzimidazole compounds for beta-amyloid peptide-associated disorders

Oct. 18, 1996

AM-424 available for licensing

Oct. 18, 1996

Seventeenth approval for Rilutek

Oct. 18, 1996

Promising clinical results with MS vaccine

Oct. 18, 1996

Berlex suit relating to Avonex dismissed

Oct. 18, 1996

GV-4000 available for licensing

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...